e 4031 has been researched along with prednisone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Accordi, B; Amedei, A; Arcangeli, A; Basso, G; Becchetti, A; Campana, D; Cilia, E; Crociani, O; D'Amico, M; De Lorenzo, E; Masselli, M; Pillozzi, S; Veltroni, M | 1 |
1 other study(ies) available for e 4031 and prednisone
Article | Year |
---|---|
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Membrane; Cells, Cultured; Coculture Techniques; Doxorubicin; Drug Resistance, Neoplasm; Ether-A-Go-Go Potassium Channels; Female; Humans; Integrin beta1; Mesenchymal Stem Cells; Mice; Mice, Inbred NOD; Mice, SCID; Multiprotein Complexes; Piperidines; Potassium Channel Blockers; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyridines; Receptors, CXCR4; RNA Interference; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |